Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board

Summary

The bill bars managed‑care organizations, insurers, nonprofit health service plans and HMOs from imposing prior‑authorization, step‑therapy or fail‑first rules on prescription drugs that the Prescription Drug Affordability Board has reviewed and either set a payment limit for, issued a policy recommendation on, or found not to pose an affordability challenge. It also prevents those entities from limiting coverage, raising cost‑sharing, or removing such drugs from formularies except for safety or supply issues. The goal is to improve patient access to affordable medicines.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share